Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycythemia Vera × Erlotinib Hydrochloride × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Thrombocytosis 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Breast Neoplasms 1 Blast Crisis 1 Anemia 1

Interventions

ruxolitinib 27 fludarabine phosphate 27 Peripheral Blood Stem Cell Transplantation 22 Cyclophosphamide 22 Busulfan 17 Whole-Body Irradiation 14 Mycophenolic Acid 13 Tacrolimus 12 Cyclosporine 11 Methotrexate 10 Antilymphocyte Serum 10 fludarabine 8 Hydroxyurea 8 Aspirin 8 Melphalan 7 Filgrastim 7 Etoposide 7 Decitabine 7 Cytarabine 6 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 6 peginterferon alfa-2a 5 givinostat hydrochloride 5 givinostat 5 Radiotherapy 5 Biopsy 5 Stem Cell Transplantation 4 Prednisone 4 Phlebotomy 4 Methylprednisolone 4 Imatinib Mesylate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01038856 2020-08-24

OSI-TAR-766

University of Oklahoma

Phase 2 Terminated

5 enrolled 6 charts

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡